Trying to condense three, incredibly personal RPGs into a streamlined narrative would only disappoint. The Mass Effect show ...

Upcoming topline results from the ongoing TX45 clinical program includes Phase 1b hemodynamic, proof-of-concept trial data expected in late 1Q or early 2Q’2025, and APEX Phase 2 clinical trial data ...

Under Donald Trump and Joe Biden alike, the US has been determined to “reshore” chipmaking. Now money and colossal ...

A meme purports to outline what it calls "The Trump-Vance Project 2025 Plan," although both U.S. President-elect Trump and ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

Management to host conference call today at 8:30 a.m. ET LEXINGTON, Mass., Nov. 14, 2024 /PRNewswire/ -- Curis, Inc. ("Curis") (NASDAQ: CRIS), a biotechnology ...

For those in training who say, “I’m not sure I’m up to this,” as they struggle against the avalanche of new tasks and ...

The company expects to submit an Investigational New Drug (IND) Application for its IL-18 program ... Meeting of the Society ...

A perceived lack of communication is fueling a surge of opposition to the location of Ottawa's new shelter for asylum seekers ...

Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.